Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Chiesi Pharma AB
AB
Active
Org 5568275746
Klara Norra Kyrkogata 34, 111 22
Stockholm
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2010 · 15 years old
109 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Chiesi Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1.2B
0.9B
0.6B
0.3B
0B
2021: 0.5B
0.5B
2021
2022: 0.6B (+26% vs 2021)
0.6B
+26%
2022
2023: 0.7B (+16% vs 2022)
0.7B
+16%
2023
2024: 0.9B (+18% vs 2023)
0.9B
+18%
2024
2025: 0.9B (+8% vs 2024)
0.9B
+8%
2025
EBITDA
SEK millions
67M
50M
34M
17M
0M
2021: 38M
38M
2021
2022: 43M (+13% vs 2021)
43M
+13%
2022
2023: 39M (-9% vs 2022)
39M
-9%
2023
2024: 52M (+33% vs 2023)
52M
+33%
2024
2025: 54M (+4% vs 2024)
54M
+4%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
936 277
870 456
738 731
638 756
506 939
Staff expenses
−204 336
—
—
—
—
EBITDA
53 891
51 967
39 224
42 787
38 023
Depreciation & amort.
−8 532
−7 917
−6 913
−6 286
−5 322
EBIT
46 359
44 050
32 311
36 501
32 701
Net financials
−345
1 476
2 002
−11 333
−3 184
Profit before tax
45 014
45 578
34 312
30 827
30 989
Tax
−11 732
−12 192
−8 558
−6 188
−6 611
Net profit
33 282
33 386
25 754
24 639
24 378
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
385 616
292 881
340 876
305 420
302 150
Equity
133 409
131 843
98 457
72 703
48 060
Long-term debt
0
0
0
33 365
51 252
Short-term debt
252 207
161 038
242 419
199 352
202 838
Total debt
252 207
161 038
242 419
232 717
254 090
Financial ratios
5-year trend
EBITDA margin
5,8 %
This company
15,8 %
Market median
This company
Market median
63% below market
2021
2025
Equity ratio
34,6 %
This company
38,2 %
Market median
This company
Market median
9% below market
2021
2025
Return on equity
24,9 %
This company
18,4 %
Market median
This company
Market median
35% above market
2021
2025
Net profit margin
3,6 %
This company
8,1 %
Market median
This company
Market median
56% below market
2021
2025
Asset turnover
2,43×
This company
1,12×
Market median
This company
Market median
117% above market
2021
2025
Debt / equity
1,89×
This company
0,62×
Market median
This company
Market median
205% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Chiesi Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
